BioSpace News Archive

Press Releases

Allarity Therapeutics Presents New Phase 2 Clinical Data for Stenoparib/2X-121 Showing Landmark Median Overall Survival Has Now Surpassed 25 Months

September 23, 2025
·
9 min read
Press Releases

MBX Biosciences Announces Once-Weekly Canvuparatide Achieved Primary Endpoint in Phase 2 Trial with 63% Responder Rate at 12 Weeks; 79% Responder Rate at 6 Months in Open-Label Extension

September 23, 2025
·
10 min read
Press Releases

Intellia Therapeutics to Present Longer-Term Data from the Ongoing Phase 1 Clinical Trial of Nexiguran Ziclumeran (nex-z) for the Treatment of Hereditary Transthyretin (ATTR) Amyloidosis with Polyneuropathy

September 23, 2025
·
3 min read
Press Releases

BridgeBio to Present Additional Cardiovascular Outcomes Data from ATTRibute-CM at the HFSA Annual Scientific Meeting 2025

September 23, 2025
·
2 min read
Press Releases

Palatin Earns €5.5 Million ($6.5 Million) Milestone Payment in Retinal Disease Collaboration with Boehringer Ingelheim

September 23, 2025
·
3 min read
Press Releases

Starpharma Announces a Collaboration and License Agreement with Genentech

September 23, 2025
·
2 min read
Press Releases

Plus Therapeutics Announces Additional $1.9 Million Advance Payment from CPRIT

September 23, 2025
·
7 min read
Press Releases

Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

September 23, 2025
·
4 min read
Press Releases

QuidelOrtho Announces Availability of QUICKVUE™ Influenza + SARS Test for Professional Use

September 23, 2025
·
2 min read
Press Releases

CellProthera announces peer-reviewed publication of its Phase I/IIb results on safety and feasibility of ProtheraCytes® in patients with severe heart failure post-myocardial Infarction

September 23, 2025
·
3 min read